GenSearch is pleased to announce that we will be attending the BIO-Europe Spring Conference, which will take place on 6-8 November 2023 in Munich, Germany.
Read more “Bio-Europe 2023”Swiss Biotech Day 2023
GenSearch will be attending the next Swiss Biotech day in Basel on 24-25 April 2023.
Read more “Swiss Biotech Day 2023”Season’s Greetings 2023
In 2023, dream BIG (and beyond)
Bio-Europe 2022 Leipzig
Meet us at Bio Europe 2022 to digitally bring together the life science community for global dealmaking.
Read more “Bio-Europe 2022 Leipzig”Sachs Annual Biotech in Europe Forum 2022 Basel
Heiko Bruhn will be present at the @SachsAssociates 22nd Annual #Biotech in Europe Forum which will address the main challenges in investment, partnering and alliance management and prospects for 2023.
Read more “Sachs Annual Biotech in Europe Forum 2022 Basel”GenSearch’s 10+2 anniversary
It was a great pleasure to celebrate GenSearch’s 10+2 anniversary. Watching the sunset on the Seine with a cool summer breeze with so many of you was just perfect!
Read more “GenSearch’s 10+2 anniversary”Swiss Biotech Day 2022
Heiko Bruhn will be moderating a round table entitled “Attract & retain talents” at the Swiss Biotech Day.
Read more “Swiss Biotech Day 2022”Building a European biotech business in a post-pandemic world
In a lively evening at the HealthTech Basel dinner hosted by GenSearch and PwC in October, guests heard from Dr. Sarah Holland, Chief Business Officer of VectivBio, and Orlando Oliveira, former SVP, Head of International at TESARO and Agios, about their experiences of building biotech businesses in Europe.
Read more “Building a European biotech business in a post-pandemic world”“Building a European Biotech Business in a post pandemic world”
On 21st October 2021 GenSearch and PwC Switzerland held a Healthtech Dinner in Basel. Our speakers Sarah Holland & Orlando Oliveira spoke about “Building a European Biotech Business in a post pandemic world” l with Heiko Bruhn, Christian Isler & PwC Switzerland.
Read more ““Building a European Biotech Business in a post pandemic world””